Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE)
Clinical trial NCT02436668 · COMPLETED
Trial details
- NCT number
- NCT02436668
- Sponsor
- Pharmacyclics LLC.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2018-10-01
- Enrollment
- 430
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.